HomeNewsBusinessCompaniesLupin gets final US FDA nod for generic antiepileptic drug

Lupin gets final US FDA nod for generic antiepileptic drug

Lupin’s subsidiary Lupin Pharmaceuticals has received final approval from US Food and Drugs Administration (FDA) for its abbreviated new drug application to market a generic version of anti-epilepsy drug Levetiracetam extended release tablets.

September 14, 2011 / 16:11 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Moneycontrol Bureau

Lupin

first published: Sep 14, 2011 02:10 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347